Liege, Belgium

Carol Deby


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1995-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Carol Deby: Innovator in Human Myeloperoxidase Research

Introduction

Carol Deby is a prominent inventor based in Liege, Belgium. She has made significant contributions to the field of biochemistry, particularly in the study and application of human myeloperoxidase. With a total of three patents to her name, her work has implications for therapeutic applications in medicine.

Latest Patents

Carol Deby's latest patents focus on human myeloperoxidase and its therapeutic applications. One of her patents describes a method for producing human myeloperoxidase by culturing prokaryotic or eukaryotic cells that have been transformed by a vector designed for the expression of this enzyme. Another patent outlines a method for preparing biologically active human myeloperoxidase, detailing the steps involved in creating a vector that includes plasmid pNIV2703. This plasmid features a cassette that contains a complete DNA sequence for human myeloperoxidase, which is crucial for its expression in CHO cells.

Career Highlights

Throughout her career, Carol has worked with esteemed institutions such as Université Libre de Bruxelles and La Région Wallonne. Her research has not only advanced scientific understanding but has also paved the way for potential therapeutic applications of human myeloperoxidase.

Collaborations

Some of her notable coworkers include Joel Pincemail and Alex Bollen. Their collaborative efforts have contributed to the success of her research projects and patents.

Conclusion

Carol Deby stands out as an influential inventor in the field of biochemistry, particularly through her work on human myeloperoxidase. Her patents and collaborations reflect her commitment to advancing medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…